Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendimagegn Ghidey

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biometrics|December 21, 2004
Smooth random effects distribution in a linear mixed modelWendimagegn Ghidey, Emmanuel Lesaffre, Paul Eilers
Statistical Methods in Medical Research|June 20, 2008
A comparison of methods for estimating the random effects distribution of a linear mixed modelWendimagegn Ghidey, Emmanuel Lesaffre, Geert Verbeke
Statistical Methods in Medical Research|September 13, 2011
Modelling the effect of baseline risk in meta-analysis: a review from the perspective of errors-in-variables regressionWendimagegn Ghidey, Theo Stijnen, Hans C van Houwelingen
Dysphagia|January 29, 2013
Risk model and nomogram for dysphagia and xerostomia prediction in head and neck cancer patients treated by radiotherapy and/or chemotherapyDavid N Teguh, Peter C Levendag, Wendimagegn Ghidey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2015
Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patientsMarianne Linthorst, Margreet Baaijens, Ruud Wiggenraad, et al.
The Lancet. Oncology|March 13, 2016
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trialShafak Aluwini, Floris Pos, Erik Schimmel, et al.
Nature Genetics|September 30, 2010
Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritisDiane van der Woude, Wendimagegn Ghidey Alemayehu, Willem Verduijn, et al.
The Lancet. Oncology|June 25, 2016
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trialLuca Incrocci, Ruud C Wortel, Wendimagegn Ghidey Alemayehu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 28, 2015
Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancerShafak Aluwini, Wendy M H Busser, Wendimagegn Ghidey Alemayehu, et al.
The Lancet. Oncology|February 7, 2015
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trialShafak Aluwini, Floris Pos, Erik Schimmel, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biometrics|December 21, 2004
Smooth random effects distribution in a linear mixed modelWendimagegn Ghidey, Emmanuel Lesaffre, Paul Eilers
Statistical Methods in Medical Research|June 20, 2008
A comparison of methods for estimating the random effects distribution of a linear mixed modelWendimagegn Ghidey, Emmanuel Lesaffre, Geert Verbeke
Statistical Methods in Medical Research|September 13, 2011
Modelling the effect of baseline risk in meta-analysis: a review from the perspective of errors-in-variables regressionWendimagegn Ghidey, Theo Stijnen, Hans C van Houwelingen
Dysphagia|January 29, 2013
Risk model and nomogram for dysphagia and xerostomia prediction in head and neck cancer patients treated by radiotherapy and/or chemotherapyDavid N Teguh, Peter C Levendag, Wendimagegn Ghidey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2015
Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patientsMarianne Linthorst, Margreet Baaijens, Ruud Wiggenraad, et al.
The Lancet. Oncology|March 13, 2016
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trialShafak Aluwini, Floris Pos, Erik Schimmel, et al.
Nature Genetics|September 30, 2010
Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritisDiane van der Woude, Wendimagegn Ghidey Alemayehu, Willem Verduijn, et al.
The Lancet. Oncology|June 25, 2016
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trialLuca Incrocci, Ruud C Wortel, Wendimagegn Ghidey Alemayehu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 28, 2015
Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancerShafak Aluwini, Wendy M H Busser, Wendimagegn Ghidey Alemayehu, et al.
The Lancet. Oncology|February 7, 2015
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trialShafak Aluwini, Floris Pos, Erik Schimmel, et al.
Pageof 2